N	Concordance
1	02 patients with relapsed or refractory Hodgkin's disease were treated with high
2	ymphomas, there is an increased risk of Hodgkin's disease in patients with immun
3	 predominantly males. Nodular sclerosis Hodgkin's disease is found most frequent
4	 disease.  Specifically, HIV-associated Hodgkin's disease presents in a more ag
5	summary containing information on adult Hodgkin's disease is also  available in 
6	out doubt, the benefits of treatment of Hodgkin's disease outweigh the risk of 
7	64 patients with clinical stage I or II Hodgkin's disease were treated with init
8	e survival rate in a cohort of relapsed Hodgkin's disease and non-Hodgkin's lym
9	 T-cell lines from patients with active Hodgkin's disease or Hodgkin's disease 
10	on  First-line therapy against advanced Hodgkin's disease may yield a 65% "cure"
11	fradiaphragmatic and supradiaphragmatic Hodgkin's disease receiving similar trea
12	  The treatment of choice for localized Hodgkin's disease in children has evolve
13	cells of nodular lymphocyte-predominant Hodgkin's disease represent a monoclonal
14	n treatment and  follow-up of childhood Hodgkin's disease can differ from those 
15	e on radiotherapy alone for early-stage Hodgkin's disease is based  on 50 years 
16	   CD45+, while the profile for classic Hodgkin's disease is CD15+, CD20-, CD30+
17	    Prognosis of patients with advanced Hodgkin's disease: evaluation of four pr